Tools & Calculators
Stocks
F&O
Mutual Funds
HDFC Pharma and Healthcare Reg IDCW-R
as of 23 Apr 2026, 09:05 AM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 9.81% |
| Divi's Laboratories Ltd | Healthcare | E | 8.38% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 6.62% |
| Lupin Ltd | Healthcare | E | 6.44% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 6.36% |
| Alkem Laboratories Ltd | Healthcare | E | 6.21% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 5.42% |
| Ipca Laboratories Ltd | Healthcare | E | 4.80% |
| Anthem Biosciences Ltd | Healthcare | E | 4.46% |
| Fortis Healthcare Ltd | Healthcare | E | 4.02% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | E | 3.61% |
| Acutaas Chemicals Ltd | Basic Materials | E | 3.60% |
| Laurus Labs Ltd | Healthcare | E | 2.91% |
| Metropolis Healthcare Ltd | Healthcare | E | 2.53% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 2.34% |
| Vijaya Diagnostic Centre Ltd | Healthcare | E | 2.30% |
| Eris Lifesciences Ltd Registered Shs | Healthcare | E | 2.28% |
| Sai Life Sciences Ltd | Healthcare | E | 2.09% |
| Global Health Ltd | Healthcare | E | 1.84% |
| Wockhardt Ltd | Healthcare | E | 1.73% |
| Shilpa Medicare Ltd | Healthcare | E | 1.68% |
| Dr. Lal PathLabs Ltd | Healthcare | E | 1.63% |
| Thyrocare Technologies Ltd | Healthcare | E | 1.39% |
| Jubilant Pharmova Ltd | Healthcare | E | 1.35% |
| Rubicon Research Ltd | Healthcare | E | 1.22% |
| Gland Pharma Ltd | Healthcare | E | 1.12% |
| Bajaj Healthcare Ltd | Healthcare | E | 0.92% |
| Laxmi Dental Ltd | Healthcare | E | 0.61% |
| Corona Remedies Ltd | Healthcare | E | 0.55% |
| Treps - Tri-Party Repo | - | CR | 1.88% |
| Net Current Assets | - | C | 0.12% |
Equity / Debt / Cash Split
Equity
98.24%
Cash
1.76%
Equity sector allocation
Basic Materials
3.6%
Healthcare
94.64%
Others
1.76%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.37%
61.10%
3Y Returns
+61.10%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.37%
61.10%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.37%
61.10%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Dhruv Muchhal
Risk Profile
Very High Risk
Expense Ratio
2.09%
Fund Size
₹2030.81 Cr
The HDFC Pharma and Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 9.81% |
| Divi's Laboratories Ltd | 8.38% |
| Glenmark Pharmaceuticals Ltd | 6.62% |
| Lupin Ltd | 6.44% |
| Max Healthcare Institute Ltd Ordinary Shares | 6.36% |
| Alkem Laboratories Ltd | 6.21% |
| Aster DM Healthcare Ltd Ordinary Shares | 5.42% |
| Ipca Laboratories Ltd | 4.80% |
| Anthem Biosciences Ltd | 4.46% |
| Fortis Healthcare Ltd | 4.02% |
| Krishna Institute of Medical Sciences Ltd | 3.61% |
| Acutaas Chemicals Ltd | 3.60% |
| Laurus Labs Ltd | 2.91% |
| Metropolis Healthcare Ltd | 2.53% |
| Torrent Pharmaceuticals Ltd | 2.34% |
| Vijaya Diagnostic Centre Ltd | 2.30% |
| Eris Lifesciences Ltd Registered Shs | 2.28% |
| Sai Life Sciences Ltd | 2.09% |
| Global Health Ltd | 1.84% |
| Wockhardt Ltd | 1.73% |
| Shilpa Medicare Ltd | 1.68% |
| Dr. Lal PathLabs Ltd | 1.63% |
| Thyrocare Technologies Ltd | 1.39% |
| Jubilant Pharmova Ltd | 1.35% |
| Rubicon Research Ltd | 1.22% |
| Gland Pharma Ltd | 1.12% |
| Bajaj Healthcare Ltd | 0.92% |
| Laxmi Dental Ltd | 0.61% |
| Corona Remedies Ltd | 0.55% |
| Treps - Tri-Party Repo | 1.88% |
| Net Current Assets | 0.12% |
The HDFC Pharma and Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 3.60% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 94.64% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in HDFC Pharma and Healthcare Reg IDCW-R:
The exit load of HDFC Pharma and Healthcare Reg IDCW-R is as follows:
Exit load of 1.0%, if redeemed within 1 year
.The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy